Structural investigations of anthranilimide derivatives by CoMFA and CoMSIA 3D-QSAR studies reveal novel insight into their structures toward glycogen phosphorylase inhibition

Abstract

In the present work, three-dimensional quantitative structure–activity relationship (3-D QSAR) studies on a set of 70 anthranilimide compounds has been performed using docking-based as well as substructure-based molecular alignments. This resulted in the selection of more statistically relevant substructure-based alignment for further studies. Further, molecular models with good predictive power were derived using CoMFA (r ²= 0.997; Q ²= 0.578) and CoMSIA (r ²= 0.976; Q ²= 0.506), for predicting the biological activity of new compounds. The so-developed contour plots identified several key features of the compounds explaining wide activity ranges. Based on the information derived from the CoMFA contour maps, novel leads were proposed which showed better predicted activity with respect to the already reported systems. Thus, the present study not only offers a highly significant predictive QSAR model for anthranilimide derivatives as glycogen phosphorylase (GP) inhibitors which can eventually assist and complement the rational drug-design attempts, but also proposes a highly predictive pharmacophore model as a guide for further development of selective and more potent GP inhibitors as anti-diabetic agents.

Keywords:

• CoMFA
• CoMSIA
• glycogen phosphorylase
• QSAR
• type 2 diabetes

Acknowledgements

This manuscript is CDRI communication number 8009. This work was supported by the grants from Council of Scientific and Industrial Research (CSIR-India) funded network project NWP0034 (Validation of identified screening models and development of new alternative models for evaluation of new drug entities). US thanks CSIR for a fellowship.